ENOV Enovis CORP

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: Orthopedic solutions via two segments—Prevention & Recovery (P&R) and Reconstructive (Recon) with global manufacturing and sales
• • New emphasis on Recon segment growth via $865.6M Lima acquisition in Jan 2024, adding digital innovation and customized hardware

Risk Factors

• • Sarbanes-Oxley Act compliance risk from failed internal control integration at acquisitions, e.g., Lima Acquisition, possibly causing material misstatements in financial reports
• • Geopolitical risk from supply chain in China and Asia; political instability risks disrupting access to raw materials critical to manufacturing

Management Discussion & Analysis

• • Revenue $2.248B, up 5.1% YoY: P&R $1.137B (+$39M), Recon $1.111B (+$101.4M)
• • Operating loss margin worsened: P&R (32.9)% vs (29.3)%, Recon (67.5)% vs (45.0)% in 2024 due to goodwill impairments ($387.8M P&R, $662M Recon)

Risk Factors

• • New Goodwill impairment risk triggered by 40% stock price decline, recognized $541M impairment Q3 2025 due to sustained market capitalization decrease
• • Updated impairment risk: total $1.186B Goodwill impairments recognized including $645M in 2024 annual test and $541M in 2025 interim assessment

What are the latest ENOV SEC filings in 2026?

Enovis CORP (ENOV) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on February 26, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did ENOV file its most recent 10-K annual report?

Enovis CORP (ENOV) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view ENOV 10-Q quarterly reports?

Enovis CORP (ENOV)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every ENOV 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has ENOV filed recently?

Enovis CORP (ENOV)'s most recent 8-K was filed on February 26, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find ENOV insider trading activity (Form 4)?

SignalX aggregates every ENOV Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does ENOV file with the SEC?

Enovis CORP (ENOV) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ENOV filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Enovis CORP (ENOV).

What is ENOV's SEC CIK number?

Enovis CORP (ENOV)'s SEC CIK (Central Index Key) number is 1420800. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1420800 to look up all ENOV filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find ENOV return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Enovis CORP (ENOV) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.